Literature DB >> 35694095

Radical surgery for pseudo-ovarian malignancy: a case report of bowel endometriosis with massive ascites.

Yiting Bao1, Wu Huang1, Liangqing Yao1, Lei Yuan1.   

Abstract

Background: Endometriosis is a disturbing condition affecting about 10% of all reproductive aged women. The most severe form of endometriosis is deeply infiltrative endometriosis (DIE). Bowel is commonly affected in DIE. Treatment options of bowel endometriosis include surgery and medication, depending on many factors such as age, the severity of symptoms and desire for pregnancy. At present, the individualized comprehensive management of bowel endometriosis is still under exploration. Here we report an uncommon case of bowel endometriosis treated by radical surgery and postoperative high-dose progestin to enrich the clinical experience. Case Description: A 37-year-old woman was admitted to our hospital for suspected ovarian malignancy in the presence of pelvic mass, massive ascites and elevated CA-125. A laparoscopic radical surgery was performed, and she was diagnosed with bowel endometriosis. Considering the patient's high recurrence risk indicated by bowel endometriosis, massive ascites, severe adhesions, and dysmenorrhea, six-course gonadotropin-releasing hormone agonists therapy followed by high-dose progestin (two levonorgestrel intrauterine systems and subdermal implants) was administrated postoperatively to improve symptoms and prevent recurrence. No recurrence in bowels was observed by November 2021 (53 months). Conclusions: Both patient's desire and condition should be considered in the management of symptomatic bowel endometriosis. Optimal surgical removal is of great significance and individualized hormonal therapy may provide an additional component. 2022 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Bowel endometriosis; ascites; case report; hormonal therapy; radical surgery

Year:  2022        PMID: 35694095      PMCID: PMC9177284          DOI: 10.21037/gs-21-895

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  28 in total

Review 1.  Progestin therapy in endometriosis.

Authors:  Altay Gezer; Engin Oral
Journal:  Womens Health (Lond)       Date:  2015-09-21

Review 2.  An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.

Authors:  I C Chi
Journal:  Contraception       Date:  1991-12       Impact factor: 3.375

Review 3.  Surgical treatment of deeply infiltrating endometriosis with colorectal involvement.

Authors:  Christel Meuleman; Carla Tomassetti; André D'Hoore; Ben Van Cleynenbreugel; Freddy Penninckx; Ignace Vergote; Thomas D'Hooghe
Journal:  Hum Reprod Update       Date:  2011-01-13       Impact factor: 15.610

Review 4.  Bowel endometriosis: diagnosis and management.

Authors:  Camran Nezhat; Anjie Li; Rebecca Falik; Daniel Copeland; Gity Razavi; Alexandra Shakib; Catalina Mihailide; Holden Bamford; Lucia DiFrancesco; Salli Tazuke; Pejman Ghanouni; Homero Rivas; Azadeh Nezhat; Ceana Nezhat; Farr Nezhat
Journal:  Am J Obstet Gynecol       Date:  2017-10-13       Impact factor: 8.661

Review 5.  Hormonal treatments for endometriosis: The endocrine background.

Authors:  Silvia Vannuccini; Sara Clemenza; Margherita Rossi; Felice Petraglia
Journal:  Rev Endocr Metab Disord       Date:  2021-08-17       Impact factor: 9.306

6.  The impact of laparoscopic surgery on the symptoms and wellbeing of patients with deep infiltrating endometriosis and bowel involvement.

Authors:  Rogério Serafim Parra; Marley Ribeiro Feitosa; Hugo Parra de Camargo; Fernando Passador Valério; José Vitor Cabral Zanardi; José Joaquim Ribeiro da Rocha; Omar Féres
Journal:  J Psychosom Obstet Gynaecol       Date:  2020-06-15       Impact factor: 2.949

Review 7.  Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.

Authors:  Alexis J Bick; Renate Louw-du Toit; Salndave B Skosana; Donita Africander; Janet P Hapgood
Journal:  Pharmacol Ther       Date:  2020-12-13       Impact factor: 13.400

8.  Cohort study to evaluate efficacy, safety and acceptability of a two-rod contraceptive implant during third, fourth and fifth year of product use in China.

Authors:  Y Che; D Taylor; D Luo; L Y Maldonado; M Wang; S Wevill; H Vahdat; X Han; V Halpern; L Dorflinger; M J Steiner
Journal:  Contracept X       Date:  2019

9.  Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis.

Authors:  Andrew Zakhari; Emily Delpero; Sandra McKeown; George Tomlinson; Olga Bougie; Ally Murji
Journal:  Hum Reprod Update       Date:  2021-01-04       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.